List of Arnuity Ellipta drug patents

Arnuity Ellipta is owned by Glaxosmithkline.

Arnuity Ellipta contains Fluticasone Furoate.

Arnuity Ellipta has a total of 6 drug patents out of which 0 drug patents have expired.

Arnuity Ellipta was authorised for market use on 20 August, 2014.

Arnuity Ellipta is available in powder;inhalation dosage forms.

The generics of Arnuity Ellipta are possible to be released after 11 October, 2030.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9333310 GLAXOSMITHKLINE Medicament dispenser
Oct, 2027

(4 years from now)

US8113199 GLAXOSMITHKLINE Counter for use with a medicament dispenser
Oct, 2027

(4 years from now)

US8161968 GLAXOSMITHKLINE Medicament dispenser
Feb, 2028

(5 years from now)

US8201556 GLAXOSMITHKLINE Medicament dispenser
Feb, 2029

(6 years from now)

US8534281 GLAXOSMITHKLINE Manifold for use in medicament dispenser
Mar, 2030

(7 years from now)

US8746242 GLAXOSMITHKLINE Medicament dispenser
Oct, 2030

(7 years from now)

Drugs and Companies using FLUTICASONE FUROATE ingredient

Market Authorisation Date: 20 August, 2014

Treatment: NA

Dosage: POWDER;INHALATION

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in